To improve patient access to India’s most cutting-edge tertiary and quaternary care, Apollo Hospitals, Chennai, held a press conference in Kolkata. Apollo’s four decades of clinical excellence, technological leadership, and patient-first outcomes were highlighted at the meeting, particularly through its Chennai Centres of Excellence, which collectively handle thousands of challenging referrals from Eastern India each year.

The press meet was attended by Dr. Narayan Mitra, DGM of Apollo Hospitals Chennai (Eastern Region); Mr. Shridhar Raman, Vice President; Dr. Ilankumaran Kaliamoorthy, Group CEO of Apollo Hospitals Chennai Region; Mr. Nagarjun Reddy, Senior General Manager of Apollo Hospitals Chennai; and Mr. Santanu Chatterjee, DGM.

Apollo Chennai is receiving more and more patients from West Bengal and nearby eastern states for high-complexity procedures in robotics, oncology, organ transplantation, advanced cardiac sciences, and critical care. With an integrated strategy, Apollo guarantees safe and easy navigation for any patient in need of sophisticated treatment, from diagnosis to procedure to follow-up.

Over 200 million patients have received top-notch care from Apollo Hospitals since its founding in 1983, making it the most reputable name in cutting-edge medicine in India. Through clinical size, specialized depth, and state-of-the-art technology, Apollo has continuously raised the bar over the course of 42 years, giving Indian patients access to international standards of treatment domestically.

Many people consider Apollo Hospitals in Chennai to be among the most cutting-edge facilities in India for sophisticated, multidisciplinary care. Chennai is frequently chosen by patients from Kolkata and Eastern India for procedures needing advanced infrastructure and high levels of skill. Among the main advantages are:

RobWith operates one of India’s highest-volume programs in urology, gynecology, gastrointestinal, ENT, and orthopaedics, with more than 22,000 robotic procedures and ten robotic systems in Chennai. This allows for increased precision, less pain, smaller incisions, quicker recovery, and better long-term results.

Proficiency in complicated cardiac procedures and surgeries for patients at high risk, backed by specialized intensive care units and interdisciplinary teams.

Precision diagnostics and tumor boards assist comprehensive cancer care that includes surgical, medical, and radiation oncology.

Extensive post-transplant continuity and successful large-scale transplant programs.

With a focus on comprehensive treatment and precision diagnosis, Apollo Chennai offers one of the most cutting-edge cancer programs in India. A multidisciplinary tumor board made up of experts in radiology, pathology, oncology, and pertinent organ-specific fields reviews each case. This guarantees seamless care, quicker decision-making, evidence-based treatment regimens, and improved results for each patient.

Apollo’s historic accomplishment of 5,000 successful liver transplants under the Apollo Liver Transplant Program—making it the first hospital group in India and the region to reach this milestone—was a major highlight of the press conference. Decades of clinical experience, standardized procedures, and exceptional results are all reflected in this.

Apollo emphasized the value of preventive care in addition to complex care through Apollo ProHealth examinations. These packages aid in the early detection of metabolic diseases, cancer, chronic illnesses, and lifestyle-related hazards, allowing for prompt intervention, less treatment burden, and better quality of life and survival.

Apollo Hospitals, Chennai, strengthened clinical partnerships, improved guidance for complex situations, and raised awareness of preventive and advanced healthcare treatments throughout the region in order to reinforce its long-term commitment to Eastern India.

Priyanka Dutta